Showing results (311-320 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|August 31, 2023
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivationJennifer Derrien, Sarah Gastineau, Antoine Frigout, et al.Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.Nature Cancer|July 1, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumorsFranz J Zemp, Zackariah Breckenridge, Hyojin Song, et al.Nature Cancer|June 23, 2026
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cellsAsmita Pathak, Palavalasa Sravya, Bruno Colon, et al.Nature Cancer|June 4, 2026
Bacterial engineering for cancer therapyNoah Chen, Zaofeng Yang, Nicholas ArpaiaNature Cancer|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trialSolange Peters, Daniel S W Tan, David E Gerber, et al.Nature Cancer|May 22, 2026
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastasesSophia Navarre, Maki N Ishibashi, Achuth Nair, et al.Nature Cancer|June 12, 2026
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targetsShih-Chun A Chu, Yi Hsiao, Chenwei Wang, et al.Nature Cancer|April 24, 2026
Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticityRaul Jimenez-Castaño, M Angela NietoNature Cancer|May 15, 2026
CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cellsChaoxiong Wang, Peixuan Zheng, Anhui Wang, et al.Pageof 67